Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03535766 · ClinicalTrials.gov registry record
An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions
A clinical trial of Lung Cancer, sponsored by St Elizabeth Healthcare.
- Completed
- Registry status
- 2,100
- Enrollment target
- 1
- Study location
NCT03535766 is a study of Lung Cancer that has completed, run by St Elizabeth Healthcare. The registered enrollment target is 2,100 participants, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (126% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03535766, a study of Lung Cancer, has completed, sponsored by St Elizabeth Healthcare.
- COMPLETED
- Registry status
- 2,100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient electronic medical records, extracting data related to the symptom presentation, diagnosis, and treatment of new diagnoses of lung cancer. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments, with data analysis evaluating time between care encounters and potential delays in care. The data will be further stratified based on system-wide changes implemented to improve efficiency, patient outcomes, and patient experience.
Conditions Studied
Study Locations (1)
Kentucky
- St. Elizabeth Healthcare - Edgewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,100 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2023-01-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03535766
The ClinicalTrials.gov registry entry for NCT03535766 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (126% higher). The listed sponsor is St Elizabeth Healthcare, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03535766 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT03535766 about?
NCT03535766 is a clinical study titled "An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions". This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient...
What is the current status of trial NCT03535766?
This trial is currently completed. The enrollment target is 2,100 participants. The study started on 2018-03-01. Estimated completion is 2023-01-09.
What conditions does trial NCT03535766 study?
This clinical trial studies the following conditions: Lung Cancer.
Who is sponsoring clinical trial NCT03535766?
This trial is sponsored by St Elizabeth Healthcare, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03535766 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.